Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06560502 · ClinicalTrials.gov registry record · NA
Modified Multi-Platform Trial Assessing Multiple CAMPs and SOC vs SOC Alone in the Treatment of DFU and VLUs
A NA study of Diabetic Foot Ulcer and Venous Leg Ulcer, sponsored by Stability Biologics.
- Recruiting
- Registry status
- NA
- Development phase
- 324
- Enrollment target
- 1
- Study location
NCT06560502 is a NA study of Diabetic Foot Ulcer and Venous Leg Ulcer that is actively recruiting participants, run by Stability Biologics. The registered enrollment target is 324 participants, above the 250-participant average among 67 other Diabetic Foot Ulcer trials with a reported enrollment target (30% higher). The trial reports 1 study location across 1 state.
The verdict
NCT06560502, a NA study of Diabetic Foot Ulcer and Venous Leg Ulcer, is actively recruiting participants, sponsored by Stability Biologics.
- RECRUITING
- Registry status
- NA
- Development phase
- 324 participants
- Enrollment target
- 1
- Study location
Study Summary
This is a multicenter, prospective, randomized controlled modified multi-platform (matriarch) trial evaluating several cellular, acellular, and matrix-like products (CAMPs) and standard of care versus standard of care alone in the management of nonhealing diabetic foot and venous leg ulcers.
Conditions Studied
Interventions
- OTHER Standard of Care-DFU
- OTHER AmnioCore - DFU
- OTHER Amnio Quad-Core - DFU
- OTHER Standard of Care-VLU
- OTHER Amnio Tri-Core - VLU
Study Locations (1)
Ohio
- Cutting Edge Research - Circleville
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 324 participants |
| Start Date | 2024-08-01 |
| Est. Completion | 2026-08 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06560502
The ClinicalTrials.gov registry entry for NCT06560502 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 324 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 250-participant average among 67 other Diabetic Foot Ulcer trials with a reported enrollment target (30% higher). The listed sponsor is Stability Biologics, which has 1 total studies on file at ClinicalTrials.gov.
The record links to 4 conditions, with Diabetic Foot Ulcer appearing as the primary indexed condition, and to 5 interventions - of which Standard of Care-DFU is the first listed.
NCT06560502 reports 1 study location spanning 1 distinct geographic area - top geographies include Ohio.
Frequently Asked Questions
What is clinical trial NCT06560502 about?
NCT06560502 is a clinical study titled "Modified Multi-Platform Trial Assessing Multiple CAMPs and SOC vs SOC Alone in the Treatment of DFU and VLUs". This is a multicenter, prospective, randomized controlled modified multi-platform (matriarch) trial evaluating several cellular, acellular, and matrix-like products (CAMPs) and standard of care versus standard of care alone in the management of nonhealing diabetic foot and venous leg ulcers.
What is the current status of trial NCT06560502?
This trial is currently recruiting. It is a NA study. The enrollment target is 324 participants. The study started on 2024-08-01. Estimated completion is 2026-08.
What conditions does trial NCT06560502 study?
This clinical trial studies the following conditions: Diabetic Foot Ulcer, Venous Leg Ulcer, Ulcer Foot, Leg Ulcer.
What interventions are being tested in trial NCT06560502?
The interventions under investigation include: Standard of Care-DFU (OTHER), AmnioCore - DFU (OTHER), Amnio Quad-Core - DFU (OTHER), Standard of Care-VLU (OTHER), Amnio Tri-Core - VLU (OTHER).
Who is sponsoring clinical trial NCT06560502?
This trial is sponsored by Stability Biologics, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06560502 being conducted?
This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Diabetic Foot Ulcer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Feasibility and Effectiveness of a Remote Monitoring Program for the Treatment of Diabetic Foot Ulcers
RECRUITING · NA
-
Study Assessing Complete Wound Healing by Comparing Surgenex® PelloGraft in Treating DFU and SanoGraft® in Treating VLU to SOC
RECRUITING · NA
-
A Clinical Investigation to Follow the Progress of Exuding Chronic Wounds Using Mepilex® Up as the Primary Dressing.
RECRUITING · NA
-
Modified Platform Trial Evaluating PpLHACM and SOC Versus SOC Alone in the Treatment of Nonhealing DFUs
RECRUITING · NA
-
Derm-Maxx in Patients With Diabetic Foot Ulcers Unresponsive to Standard of Care Treatment Alone
RECRUITING · NA
-
Exercise Enhances Wound Healing in Patients With Diabetic Foot Ulcers
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.